SlideShare a Scribd company logo
1 of 46
Download to read offline
Approach to HypotonicApproach to Hypotonic
InfantInfant
Dr. Vinayak Kodur
3rd year DM resident
L.T.M.M.C. Sion Mumbai
Hypotonic InfantHypotonic Infant
• Defined as decreased resistance to passive
movement, and may or may not be associated
with decreased muscle strength or weakness.
• Recognition of hypotonia in the newborn may be
straightforward, but determining the cause may
be a challenge.
• The physical examination, including a detailed
neurologic examination, is important in localizing
the site of a defect within the nervous system
(ie, central vs peripheral).
Hypotonic InfantHypotonic Infant
• History along with basic laboratory testing and
imaging aids in the differential diagnosis.
Identification of the cause is essential for
determining the prognosis for the infant,
associated morbidities, and the recurrence risk.
CaseCase
• A newborn term infant presents with poor
respiratory effort and abnormal suck and
swallow after a pregnancy complicated by
decreased fetal movement.
• Born by cesarean section because of breech
presentation.
• Physical examination shows no dysmorphic
features but significant hypotonia, without
tongue fasciculations and absent deep tendon
reflexes.
CaseCase
• The family history is negative for any muscle or
neurologic disease, early infant deaths, or
consanguinity.
• Examination of the mother is normal
(specifically evaluating for signs of myotonia).
AlgorithmAlgorithm
• History and physical examination
• Localization of hypotonia to
• central (ie, the brain and brainstem, either
diffusely or focally)
• peripheral (any component of the motor unit:
anterior horn cell, peripheral nerve,
neuromuscular junction, muscle itself)
HistoryHistory
• The history in conjunction with the physical
examination may give clues to the cause.
• The history includes prenatal, perinatal/birth,
and family history.
Family HistoryFamily History
• Neuromuscular disorders
• Maternal myotonia (shake mom’s hand to
assess for myotonia; slow release) Congenital
myotonic dystrophy
• Advanced maternal age: increased risk of
chromosomal aneuploidy
• Advanced paternal age: increased risk of de
novo mutations and new dominant diseases
• Consanguinity: Autosomal recessive disorders.
• Early infant deaths
Antenatal HistoryAntenatal History
• Maternal infection
• Teratogen exposure
• Polyhydramnios
• Maternal diseases (GDM/PIH)
• Maternal systemic lupus erythematosus
• Maternal Myasthenia Gravis.
• Decreased fetal movement
• Breech presentation.
• Shortened umbilical cord
Birth HistoryBirth History
• Breech Delivery
• Instrumentation
• Perinatal asphyxia
• Trauma/delivery complications
• Maternal delivery medications
• Need for resuscitation, ventilator support
Physical ExaminationPhysical Examination
Physical ExaminationPhysical Examination
• Differentiating central from peripheral hypotonia.
Physical ExaminationPhysical Examination
• Syndromic Vs non-syndromic cause.
• If an infant with hypotonia has dysmorphic facial
features, congenital malformations, or both, the
standard of care is to obtain a chromosomal
microarray (by either single nucleotide
polymorphism or comparative genomic
hybridization) to evaluate for chromosomal
deletions and duplications.
Syndromic CausesSyndromic Causes
• Trisomies 21/13/18
Prader Wili
Syndrome
Feeding difficulties, FTT,
Hypogonadism hyperphagic
obesity; almond-shaped palpebral
fissures; small hands and feet;
mild to moderate MR
FISH analysis of
SNRPN gene Ch 15
Smith Lemli
Opitz Synd
Microcephaly, Ptosis, anteverted
nostrils, low set ears,
micrognathia, 2-3 toe syndactyly
7 Dehydrocholesterol
reductase deficiency
with elevated serum
7-dehydrocholesterol
Zellweger
and other
peroxisomal
disorders
High forehead with flat facies,
Hepatomegaly,
Very Long chain fatty
acids and
plasmalogens
analysis
Physical ExaminationPhysical Examination
• Once an infant is determined to be hypotonic and
nondysmorphic, weakness or strength should be
evaluated.
• May be difficult to demonstrate if there are systemic
symptoms (ie, infection, altered mental status) or if the
baby is on systemic medications such as neuromuscular
blocking agents and sedatives.
• There is no direct measurement of muscle strength in
infants, but it may be assessed by observing the
awake/alert infant.
Differential DiagnosisDifferential Diagnosis
• Central hypotonia
• May have altered mental status, increased
deep tendon reflexes, Babinski sign,
persistent infantile reflexes
• HIE, Premature birth, difficult delivery
• Intracranial hemorrhage, Cerebral
malformations May be noted on prenatal
ultrasonography
Differential DiagnosisDifferential Diagnosis
• Chromosomal abnormalities
• Peroxisomal disorders Dysmorphic features
• Inborn errors of metabolism Metabolic acidosis,
hypoglycemia, hyperammonemia, lactic acidosis
• Maternal and infant drug effects
• Congenital infections or Acquired infections
Differential DiagnosisDifferential Diagnosis
• Spinal cord
• Birth trauma
• HIE
• Syringomyelia
• Anterior horn cell: Spinal muscular atrophy
Differential DiagnosisDifferential Diagnosis
• Neuromuscular junction
1. Myasthenia gravis:
• Transient acquired neonatal myasthenia
• Congenital myasthenia gravis
• Easy fatigability, recurrent aspiration,
feeding difficulty
• EMG Responds to anticholinesterase
Inhibitors ECG may show heart block
Differential DiagnosisDifferential Diagnosis
• Neuromuscular junction
2. Infantile botulism
• Facial weakness and pupillary abnormality
• Presence of toxin in food
2. Drug toxicity (magnesium, aminoglycosides)
History of drug exposure Plasma and urine
drug levels
Differential DiagnosisDifferential Diagnosis
• Peripheral nerves diagnosed by DNA
sequencing
1. Hereditary motor and sensory neuropathies
• Diminished/absent DTRs, absent Babinski and
infantile reflexes
• EMG/NCV may be helpful
1. Congenital hypomyelinating neuropathy
• Family history
1. Giant axonal neuropathy
• Family history
Differential DiagnosisDifferential Diagnosis
• Muscular Causes: may have family history and
require muscle biopsy for diagnosis
1. Muscular dystrophies
• May have elevated serum CK and aldolase, ALT
and AST may be elevated from muscle rather than
liver
1. Congenital myopathies
2. Metabolic myopathies
• May have elevated serum CK, aldolase, ALT, and
AST
1. Congenital myotonic dystrophy
• Maternal myotonia
• CTG-repeat analysis of DMPK gene
Physical Examination
CNS
Causes
Neuro-
imaging
Genetic
Studies
Biochemi
cal
Studies
Peripheral
Causes
CPK
EMG
NCV
Muscle
Biopsy
Genetic
Studies
Basic LAB StudiesBasic LAB Studies
• Septic screen
• ABG for metabolic acidosis
• Sugar levels for hypoglycemia,
• Serum electrolytes (specially sodium) and
calcium.
• Ammonia, orotic acid and plasma amino acids
for urea cycle defects,
• Urine organic acids and acyl carnitine profile for
organic acidemias,
LAB StudiesLAB Studies
• Plasma acyl carnitine and total carnitine for fatty acid
oxidation defects,
• Plasma lactate, pyruvate for disorders of
carbohydrate metabolism and mitochondrial
disorders.
• Laboratory testing of creatine kinase (CK) and
aldolase
• Helpful if there is a muscular dystrophy, but often
is normal in infants with hypotonia.
• In addition, it can be falsely elevated after difficult
deliveries.
• Elevated alanine aminotransferase (ALT) or aspartate
aminotransferase (AST) may be an indication of
Genetic StudiesGenetic Studies
• Chromosomal analysis (routine karyotype for
Down syndrome [trisomy 21]
• Analysis for microdeletions/duplications either
by chromosomal microarray or specific testing
by FISH)
• Methylation analysis of the chromosome region
of 15q11-q13 for Prader-Willi syndrome (PWS)
(detects 99% cases vs 70% with FISH)
NeuroimagingNeuroimaging
1. Neurosonogram
2. CT brain
3. MRI brain and Spine
4. MR spectroscopy
• Corpus callosal agenesis
• Migration defects
• Signal abnormalities in the white matter and
basal ganglia
• Congenital malformations
• Spine defects
EMG NCVEMG NCV
• Helpful in localizing the defect
• Technically difficult
• EMG is very accurate in the diagnosis of SMA
• NCV is helpful in investigating hereditary motor
sensory neuropathies by distinguishing between
axonal and demyelinating conditions.
• These studies can also be helpful in distinguishing
between a neuronal and a myopathic process15 and in
the diagnosis of a neuromuscular transmission defect
(congenital myasthenia gravis).
EMGEMG
• Though useful for muscular dystrophies and
congenital myopathies, EMG may missed
metabolic myopathies.
• A resting muscle does not show recordable
electrical potential but with increase force of
contraction, amplitude of potential increases.
• EMG detects electrical potential generated by
muscle cells when these cells are electrically or
neurologically activated.
• EMG shows fibrillation and muscle denervation
in SMA.
EMGEMG
Pattern of EMG Record Findings
Resting activity Muscle relaxed &
needle not moving
No activity
Insertion Activity Needle is moved to
various sampling spots
within insertion tract
Brief action potentials
Motor Unit Potential Needle is not moved
while patient makes
slight contraction.
A few motor unit action
potentials, biphasic or
triphasic,short duration
Recruitment Subject makes
progressively stronger
muscle contraction
until reaching
maximum force
Increase number of
functioning movements
until the baseline is
obscured
EMGEMG
• Motor unit potential (MUP)
• The sum of the action potentials produced in the
muscle.
• Characterized by its duration, number of phases,
amplitude, & rate of rise of first component
EMGEMG
Duration •measured from the initial take-off to the point of
return to the baseline
•5-15 ms
Phases •portion of the MUP between the departure & the
return to the baseline
•triphasic(positive, negative, positive)
•Polyphasic-MUP with more than four phase (5-15%)
Phases •measured from maximum peak of negative phase to
maximum peak of the positive phase
•0.5mV to 2mV
Rise Time •duration from the initial positive to subsequent
negative peak
•normal ↓ 500 μs
EMGEMG
Fibrillation Fasiculation
Contraction of individual
muscle fibre
Contraction of individual motor
units
cannot be seen through the
skin
visible through the skin
when muscle fibers lose
contact with their innervating
axon
occurs as a result of additional
nerve impulses generated
10-100 μV in amplitude, 1-2
ms in duration & 10 Hz in
frequency
50-500 μV in amplitude, 2-4
ms in duration & 2-20 Hz in
frequency
Neuropathy, myopathy Neuropathy
EMGEMG
Muscle BiopsyMuscle Biopsy
• If muscular dystrophy or myopathy is
suspected.17
• Basic histology can identify myopathic,
neuropathic, and dystrophic changes.
• Immunohistochemical techniques using
antibodies against muscle-specific proteins are
helpful in the diagnosis of muscular dystrophies
and myopathies.
• Electron microscopy can identify abnormalities
of organelles (such as mitochondria), and
identify inclusions and storage material.
Congenital Myotonic
dystrophy
• Mother previously
diagnosed in 50% cases
• Presents at birth
• Hypotonia, facial diplegia
with “tenting” of upper lip
• Frequently severe
respiratory distress
secondary to intercostal
and diaphragmatic muscle
weakness
Transient Neonatal
Myasthenia
• Mother usually previously
diagnosed
• Presents at birth or within
few days
• Muscle fatiguability,
generalised weakness,
hypotonia, weak cry, poor
feeding, respiratory
distress, ophthalmoplegia,
ptosis (in 15%)
Congenital Myotonic
dystrophy
• Poor suck, GI dysmotility
• Reduced muscle mass,
contractures
• Maternal history: spont
abortions, polyhydramnios,
↓ fetal movement, PPH,
delayed 2nd
stage
• Triplet repeat Chr 19: AD
Transient Neonatal
Myasthenia
• Normal pupils, normal
DTR
• Due to transplacental
passage of maternal
antibodies against acetyl
choline receptor
• Diagnosed by
edrophonium test
• Resolves in weeks
SMASMA
• A group of autosomal-recessive disorders
characterized by progressive weakness of the
lower motor neurons.
• In the early 1980s, Werdnig and Hoffman
described a disorder of progressive muscular
weakness beginning in infancy that resulted in
early death, though the age of death was
variable.
SMASMA
• Incidence 1 in 10,000 live births with a carrier
frequency of approximately 1 in 50.
• Male individuals are most frequently affected,
especially with the early-onset forms of spinal
muscular atrophy, ie, types I and II.
• SMA type I, the median survival is 7 months,
with a mortality rate of 95% by age 18 months.
SMA - TypesSMA - Types
• Acute infantile (SMA type I, or Werdnig-Hoffman
disease) onset birth to 6 months, Never sits
• Chronic infantile (SMA type II), 6-18 months,
Sits but can`t walk,
• Chronic juvenile (SMA type III or Kugelberg-
Welander disease), after 18 months, can walk.
• Adult onset (SMA type IV) forms. Mid 30.
• The genetic defects associated with SMA types
I-III are localized on chromosome 5q
SMA - PathophysiologySMA - Pathophysiology
• Each individual has 2 SMN(Survivor Motor
Neuron) genes, SMN1 and SMN2.
• More than 95% of patients with spinal muscular
atrophy have a homozygous disruption in the
SMN1 gene on chromosome 5q, caused by
mutation, deletion, or rearrangement.
• However, all patients with spinal muscular
atrophy retain at least 1 copy of SMN2, which
generates only 10% of the amount of full-length
SMN protein versus SMN1.
SMA - Clinical FeaturesSMA - Clinical Features
• 95% of patients symptomatic by 3 months.
• They have severe, progressive muscle
weakness and hypotonia.
• Bulbar dysfunction includes poor suck ability,
reduced swallowing, and respiratory failure.
• Patients have no involvement of the extraocular
muscles
• Facial weakness is often minimal or absent.
• No evidence of cerebral involvement, and
infants appear alert.
SMA - DiagnosisSMA - Diagnosis
• The creatine kinase (CK) level is typically
normal in SMA type I and normal or slightly
elevated.
• EMG shows fibrillation and muscle denervation.
SMA - DiagnosisSMA - Diagnosis
• Homozygous SMN1 gene deletion is 95%
sensitive and nearly 100% specific for the
diagnosis of SMA.
• The accuracy of prenatal prediction by means of
chorionic villi sampling and amniocentesis was
88-99%.
SMA - DiagnosisSMA - Diagnosis
Thank YouThank You

More Related Content

What's hot

Approach to a child with hypotonia
Approach to a child with hypotoniaApproach to a child with hypotonia
Approach to a child with hypotoniaNehal Shah
 
Approach to floppy infant
Approach to floppy infantApproach to floppy infant
Approach to floppy infantgopan2596
 
Approach to floppy infant
Approach to floppy infantApproach to floppy infant
Approach to floppy infantBeenish Iqbal
 
Ataxia in children
Ataxia in childrenAtaxia in children
Ataxia in childrennaseeb nn
 
Neuromuscular weakness or paralysis in children 2021
Neuromuscular weakness or paralysis in children 2021Neuromuscular weakness or paralysis in children 2021
Neuromuscular weakness or paralysis in children 2021Imran Iqbal
 
Approach to neuroregression
Approach to neuroregressionApproach to neuroregression
Approach to neuroregressiondrswarupa
 
Pediatric movement disorders
Pediatric movement disordersPediatric movement disorders
Pediatric movement disordersKiran Sharma
 
Clinical approach to the floppy child
Clinical approach to the floppy childClinical approach to the floppy child
Clinical approach to the floppy childMohd Hanafi
 
Infantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmiaInfantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmiawafaa al shehhi
 
Approach to Macro and Microcephaly
Approach to Macro and MicrocephalyApproach to Macro and Microcephaly
Approach to Macro and MicrocephalyThe Medical Post
 
Hypoxic ischemic encephalopathy: Lecture on HIE
Hypoxic ischemic encephalopathy: Lecture on HIEHypoxic ischemic encephalopathy: Lecture on HIE
Hypoxic ischemic encephalopathy: Lecture on HIESujit Shrestha
 
Approach to Milestone Regression
Approach to Milestone RegressionApproach to Milestone Regression
Approach to Milestone RegressionNeurologyKota
 
An approach to a chil with microcephaly
An approach to a chil with microcephalyAn approach to a chil with microcephaly
An approach to a chil with microcephalybhabilal
 

What's hot (20)

Approach to a child with hypotonia
Approach to a child with hypotoniaApproach to a child with hypotonia
Approach to a child with hypotonia
 
Approach to floppy infant
Approach to floppy infantApproach to floppy infant
Approach to floppy infant
 
Hypotonia in children
Hypotonia in childrenHypotonia in children
Hypotonia in children
 
Floppy infant
Floppy infantFloppy infant
Floppy infant
 
Approach to floppy infant
Approach to floppy infantApproach to floppy infant
Approach to floppy infant
 
Floppy infant
Floppy infant Floppy infant
Floppy infant
 
Floppy baby
Floppy babyFloppy baby
Floppy baby
 
Microcephaly
MicrocephalyMicrocephaly
Microcephaly
 
Ataxia in children
Ataxia in childrenAtaxia in children
Ataxia in children
 
Neuromuscular weakness or paralysis in children 2021
Neuromuscular weakness or paralysis in children 2021Neuromuscular weakness or paralysis in children 2021
Neuromuscular weakness or paralysis in children 2021
 
Approach to neuroregression
Approach to neuroregressionApproach to neuroregression
Approach to neuroregression
 
CEREBRAL PALSY
CEREBRAL PALSY CEREBRAL PALSY
CEREBRAL PALSY
 
Pediatric movement disorders
Pediatric movement disordersPediatric movement disorders
Pediatric movement disorders
 
Kernicterus
KernicterusKernicterus
Kernicterus
 
Clinical approach to the floppy child
Clinical approach to the floppy childClinical approach to the floppy child
Clinical approach to the floppy child
 
Infantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmiaInfantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmia
 
Approach to Macro and Microcephaly
Approach to Macro and MicrocephalyApproach to Macro and Microcephaly
Approach to Macro and Microcephaly
 
Hypoxic ischemic encephalopathy: Lecture on HIE
Hypoxic ischemic encephalopathy: Lecture on HIEHypoxic ischemic encephalopathy: Lecture on HIE
Hypoxic ischemic encephalopathy: Lecture on HIE
 
Approach to Milestone Regression
Approach to Milestone RegressionApproach to Milestone Regression
Approach to Milestone Regression
 
An approach to a chil with microcephaly
An approach to a chil with microcephalyAn approach to a chil with microcephaly
An approach to a chil with microcephaly
 

Similar to Hypotonic infant

Hyperekplexia in infants
Hyperekplexia in infantsHyperekplexia in infants
Hyperekplexia in infantsDr Amit Vatkar
 
Cerebral Palsy.pptx
Cerebral Palsy.pptxCerebral Palsy.pptx
Cerebral Palsy.pptxHasan Arafat
 
Neonatal seizures, dr amit vatkar, pediatric neurologist
Neonatal seizures, dr amit vatkar, pediatric neurologistNeonatal seizures, dr amit vatkar, pediatric neurologist
Neonatal seizures, dr amit vatkar, pediatric neurologistDr Amit Vatkar
 
Neonatal convulsion....assignt
Neonatal  convulsion....assigntNeonatal  convulsion....assignt
Neonatal convulsion....assigntRahul Dhaker
 
Disorders of the Neuromuscular junction
Disorders of the Neuromuscular junction Disorders of the Neuromuscular junction
Disorders of the Neuromuscular junction PGIMER,DR.RML HOSPITAL
 
Myasthenia gravis in children
Myasthenia gravis in childrenMyasthenia gravis in children
Myasthenia gravis in childrenAlsalheenAlraied
 
Stiibirth, fetal asphyxia.ppthjjchhvghuv
Stiibirth, fetal asphyxia.ppthjjchhvghuvStiibirth, fetal asphyxia.ppthjjchhvghuv
Stiibirth, fetal asphyxia.ppthjjchhvghuvssuser7d8a14
 
NeoNatal Seizures.pptx
NeoNatal Seizures.pptxNeoNatal Seizures.pptx
NeoNatal Seizures.pptxsrushtipatil68
 
Antiepileptics
AntiepilepticsAntiepileptics
AntiepilepticsAmit Kumar
 
FLOPPY INFANTneuropedicon 2017.pptx
FLOPPY INFANTneuropedicon 2017.pptxFLOPPY INFANTneuropedicon 2017.pptx
FLOPPY INFANTneuropedicon 2017.pptxKalpanaVijay3
 
Approach to Floppy Infant.ppt
Approach to Floppy Infant.pptApproach to Floppy Infant.ppt
Approach to Floppy Infant.pptOsmanHaroon3
 
Neonatal convulsion & nursing management
Neonatal convulsion & nursing managementNeonatal convulsion & nursing management
Neonatal convulsion & nursing managementABHIJIT BHOYAR
 
Ataxic Cerebral Palsy.pptx
Ataxic Cerebral Palsy.pptxAtaxic Cerebral Palsy.pptx
Ataxic Cerebral Palsy.pptxSayali Utale
 
Approach to seizures in a child
Approach to seizures in a childApproach to seizures in a child
Approach to seizures in a childCSN Vittal
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizuresAzad Haleem
 
Neonatal Seizures.pptx
Neonatal Seizures.pptxNeonatal Seizures.pptx
Neonatal Seizures.pptxAmsaluSamuel1
 

Similar to Hypotonic infant (20)

Hyperekplexia in infants
Hyperekplexia in infantsHyperekplexia in infants
Hyperekplexia in infants
 
Cerebral Palsy.pptx
Cerebral Palsy.pptxCerebral Palsy.pptx
Cerebral Palsy.pptx
 
Neonatal seizures, dr amit vatkar, pediatric neurologist
Neonatal seizures, dr amit vatkar, pediatric neurologistNeonatal seizures, dr amit vatkar, pediatric neurologist
Neonatal seizures, dr amit vatkar, pediatric neurologist
 
West Syndrome.pptx
West Syndrome.pptxWest Syndrome.pptx
West Syndrome.pptx
 
Neonatal convulsion....assignt
Neonatal  convulsion....assigntNeonatal  convulsion....assignt
Neonatal convulsion....assignt
 
Cerebral palsy
Cerebral palsyCerebral palsy
Cerebral palsy
 
Disorders of the Neuromuscular junction
Disorders of the Neuromuscular junction Disorders of the Neuromuscular junction
Disorders of the Neuromuscular junction
 
Myasthenia gravis in children
Myasthenia gravis in childrenMyasthenia gravis in children
Myasthenia gravis in children
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
 
Stiibirth, fetal asphyxia.ppthjjchhvghuv
Stiibirth, fetal asphyxia.ppthjjchhvghuvStiibirth, fetal asphyxia.ppthjjchhvghuv
Stiibirth, fetal asphyxia.ppthjjchhvghuv
 
NeoNatal Seizures.pptx
NeoNatal Seizures.pptxNeoNatal Seizures.pptx
NeoNatal Seizures.pptx
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
FLOPPY INFANTneuropedicon 2017.pptx
FLOPPY INFANTneuropedicon 2017.pptxFLOPPY INFANTneuropedicon 2017.pptx
FLOPPY INFANTneuropedicon 2017.pptx
 
Approach to Floppy Infant.ppt
Approach to Floppy Infant.pptApproach to Floppy Infant.ppt
Approach to Floppy Infant.ppt
 
Neonatal convulsion & nursing management
Neonatal convulsion & nursing managementNeonatal convulsion & nursing management
Neonatal convulsion & nursing management
 
Ataxic Cerebral Palsy.pptx
Ataxic Cerebral Palsy.pptxAtaxic Cerebral Palsy.pptx
Ataxic Cerebral Palsy.pptx
 
Approach to seizures in a child
Approach to seizures in a childApproach to seizures in a child
Approach to seizures in a child
 
Farshidmokhberi
FarshidmokhberiFarshidmokhberi
Farshidmokhberi
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
 
Neonatal Seizures.pptx
Neonatal Seizures.pptxNeonatal Seizures.pptx
Neonatal Seizures.pptx
 

More from Vinayak Kodur

Neonatal xray & spots git
Neonatal xray & spots gitNeonatal xray & spots git
Neonatal xray & spots gitVinayak Kodur
 
Stem cell and neonatology vinayak
Stem cell and neonatology vinayakStem cell and neonatology vinayak
Stem cell and neonatology vinayakVinayak Kodur
 

More from Vinayak Kodur (6)

Neonatal ecg part2
Neonatal ecg part2Neonatal ecg part2
Neonatal ecg part2
 
Neonatal ekg
Neonatal ekgNeonatal ekg
Neonatal ekg
 
Immune hydrops
Immune hydropsImmune hydrops
Immune hydrops
 
Neonatal MRI Brain
Neonatal MRI BrainNeonatal MRI Brain
Neonatal MRI Brain
 
Neonatal xray & spots git
Neonatal xray & spots gitNeonatal xray & spots git
Neonatal xray & spots git
 
Stem cell and neonatology vinayak
Stem cell and neonatology vinayakStem cell and neonatology vinayak
Stem cell and neonatology vinayak
 

Recently uploaded

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 

Recently uploaded (20)

Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 

Hypotonic infant

  • 1. Approach to HypotonicApproach to Hypotonic InfantInfant Dr. Vinayak Kodur 3rd year DM resident L.T.M.M.C. Sion Mumbai
  • 2. Hypotonic InfantHypotonic Infant • Defined as decreased resistance to passive movement, and may or may not be associated with decreased muscle strength or weakness. • Recognition of hypotonia in the newborn may be straightforward, but determining the cause may be a challenge. • The physical examination, including a detailed neurologic examination, is important in localizing the site of a defect within the nervous system (ie, central vs peripheral).
  • 3. Hypotonic InfantHypotonic Infant • History along with basic laboratory testing and imaging aids in the differential diagnosis. Identification of the cause is essential for determining the prognosis for the infant, associated morbidities, and the recurrence risk.
  • 4. CaseCase • A newborn term infant presents with poor respiratory effort and abnormal suck and swallow after a pregnancy complicated by decreased fetal movement. • Born by cesarean section because of breech presentation. • Physical examination shows no dysmorphic features but significant hypotonia, without tongue fasciculations and absent deep tendon reflexes.
  • 5. CaseCase • The family history is negative for any muscle or neurologic disease, early infant deaths, or consanguinity. • Examination of the mother is normal (specifically evaluating for signs of myotonia).
  • 6. AlgorithmAlgorithm • History and physical examination • Localization of hypotonia to • central (ie, the brain and brainstem, either diffusely or focally) • peripheral (any component of the motor unit: anterior horn cell, peripheral nerve, neuromuscular junction, muscle itself)
  • 7. HistoryHistory • The history in conjunction with the physical examination may give clues to the cause. • The history includes prenatal, perinatal/birth, and family history.
  • 8. Family HistoryFamily History • Neuromuscular disorders • Maternal myotonia (shake mom’s hand to assess for myotonia; slow release) Congenital myotonic dystrophy • Advanced maternal age: increased risk of chromosomal aneuploidy • Advanced paternal age: increased risk of de novo mutations and new dominant diseases • Consanguinity: Autosomal recessive disorders. • Early infant deaths
  • 9. Antenatal HistoryAntenatal History • Maternal infection • Teratogen exposure • Polyhydramnios • Maternal diseases (GDM/PIH) • Maternal systemic lupus erythematosus • Maternal Myasthenia Gravis. • Decreased fetal movement • Breech presentation. • Shortened umbilical cord
  • 10. Birth HistoryBirth History • Breech Delivery • Instrumentation • Perinatal asphyxia • Trauma/delivery complications • Maternal delivery medications • Need for resuscitation, ventilator support
  • 12. Physical ExaminationPhysical Examination • Differentiating central from peripheral hypotonia.
  • 13. Physical ExaminationPhysical Examination • Syndromic Vs non-syndromic cause. • If an infant with hypotonia has dysmorphic facial features, congenital malformations, or both, the standard of care is to obtain a chromosomal microarray (by either single nucleotide polymorphism or comparative genomic hybridization) to evaluate for chromosomal deletions and duplications.
  • 14. Syndromic CausesSyndromic Causes • Trisomies 21/13/18 Prader Wili Syndrome Feeding difficulties, FTT, Hypogonadism hyperphagic obesity; almond-shaped palpebral fissures; small hands and feet; mild to moderate MR FISH analysis of SNRPN gene Ch 15 Smith Lemli Opitz Synd Microcephaly, Ptosis, anteverted nostrils, low set ears, micrognathia, 2-3 toe syndactyly 7 Dehydrocholesterol reductase deficiency with elevated serum 7-dehydrocholesterol Zellweger and other peroxisomal disorders High forehead with flat facies, Hepatomegaly, Very Long chain fatty acids and plasmalogens analysis
  • 15. Physical ExaminationPhysical Examination • Once an infant is determined to be hypotonic and nondysmorphic, weakness or strength should be evaluated. • May be difficult to demonstrate if there are systemic symptoms (ie, infection, altered mental status) or if the baby is on systemic medications such as neuromuscular blocking agents and sedatives. • There is no direct measurement of muscle strength in infants, but it may be assessed by observing the awake/alert infant.
  • 16. Differential DiagnosisDifferential Diagnosis • Central hypotonia • May have altered mental status, increased deep tendon reflexes, Babinski sign, persistent infantile reflexes • HIE, Premature birth, difficult delivery • Intracranial hemorrhage, Cerebral malformations May be noted on prenatal ultrasonography
  • 17. Differential DiagnosisDifferential Diagnosis • Chromosomal abnormalities • Peroxisomal disorders Dysmorphic features • Inborn errors of metabolism Metabolic acidosis, hypoglycemia, hyperammonemia, lactic acidosis • Maternal and infant drug effects • Congenital infections or Acquired infections
  • 18. Differential DiagnosisDifferential Diagnosis • Spinal cord • Birth trauma • HIE • Syringomyelia • Anterior horn cell: Spinal muscular atrophy
  • 19. Differential DiagnosisDifferential Diagnosis • Neuromuscular junction 1. Myasthenia gravis: • Transient acquired neonatal myasthenia • Congenital myasthenia gravis • Easy fatigability, recurrent aspiration, feeding difficulty • EMG Responds to anticholinesterase Inhibitors ECG may show heart block
  • 20. Differential DiagnosisDifferential Diagnosis • Neuromuscular junction 2. Infantile botulism • Facial weakness and pupillary abnormality • Presence of toxin in food 2. Drug toxicity (magnesium, aminoglycosides) History of drug exposure Plasma and urine drug levels
  • 21. Differential DiagnosisDifferential Diagnosis • Peripheral nerves diagnosed by DNA sequencing 1. Hereditary motor and sensory neuropathies • Diminished/absent DTRs, absent Babinski and infantile reflexes • EMG/NCV may be helpful 1. Congenital hypomyelinating neuropathy • Family history 1. Giant axonal neuropathy • Family history
  • 22. Differential DiagnosisDifferential Diagnosis • Muscular Causes: may have family history and require muscle biopsy for diagnosis 1. Muscular dystrophies • May have elevated serum CK and aldolase, ALT and AST may be elevated from muscle rather than liver 1. Congenital myopathies 2. Metabolic myopathies • May have elevated serum CK, aldolase, ALT, and AST 1. Congenital myotonic dystrophy • Maternal myotonia • CTG-repeat analysis of DMPK gene
  • 24. Basic LAB StudiesBasic LAB Studies • Septic screen • ABG for metabolic acidosis • Sugar levels for hypoglycemia, • Serum electrolytes (specially sodium) and calcium. • Ammonia, orotic acid and plasma amino acids for urea cycle defects, • Urine organic acids and acyl carnitine profile for organic acidemias,
  • 25. LAB StudiesLAB Studies • Plasma acyl carnitine and total carnitine for fatty acid oxidation defects, • Plasma lactate, pyruvate for disorders of carbohydrate metabolism and mitochondrial disorders. • Laboratory testing of creatine kinase (CK) and aldolase • Helpful if there is a muscular dystrophy, but often is normal in infants with hypotonia. • In addition, it can be falsely elevated after difficult deliveries. • Elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST) may be an indication of
  • 26. Genetic StudiesGenetic Studies • Chromosomal analysis (routine karyotype for Down syndrome [trisomy 21] • Analysis for microdeletions/duplications either by chromosomal microarray or specific testing by FISH) • Methylation analysis of the chromosome region of 15q11-q13 for Prader-Willi syndrome (PWS) (detects 99% cases vs 70% with FISH)
  • 27. NeuroimagingNeuroimaging 1. Neurosonogram 2. CT brain 3. MRI brain and Spine 4. MR spectroscopy • Corpus callosal agenesis • Migration defects • Signal abnormalities in the white matter and basal ganglia • Congenital malformations • Spine defects
  • 28. EMG NCVEMG NCV • Helpful in localizing the defect • Technically difficult • EMG is very accurate in the diagnosis of SMA • NCV is helpful in investigating hereditary motor sensory neuropathies by distinguishing between axonal and demyelinating conditions. • These studies can also be helpful in distinguishing between a neuronal and a myopathic process15 and in the diagnosis of a neuromuscular transmission defect (congenital myasthenia gravis).
  • 29. EMGEMG • Though useful for muscular dystrophies and congenital myopathies, EMG may missed metabolic myopathies. • A resting muscle does not show recordable electrical potential but with increase force of contraction, amplitude of potential increases. • EMG detects electrical potential generated by muscle cells when these cells are electrically or neurologically activated. • EMG shows fibrillation and muscle denervation in SMA.
  • 30. EMGEMG Pattern of EMG Record Findings Resting activity Muscle relaxed & needle not moving No activity Insertion Activity Needle is moved to various sampling spots within insertion tract Brief action potentials Motor Unit Potential Needle is not moved while patient makes slight contraction. A few motor unit action potentials, biphasic or triphasic,short duration Recruitment Subject makes progressively stronger muscle contraction until reaching maximum force Increase number of functioning movements until the baseline is obscured
  • 31. EMGEMG • Motor unit potential (MUP) • The sum of the action potentials produced in the muscle. • Characterized by its duration, number of phases, amplitude, & rate of rise of first component
  • 32. EMGEMG Duration •measured from the initial take-off to the point of return to the baseline •5-15 ms Phases •portion of the MUP between the departure & the return to the baseline •triphasic(positive, negative, positive) •Polyphasic-MUP with more than four phase (5-15%) Phases •measured from maximum peak of negative phase to maximum peak of the positive phase •0.5mV to 2mV Rise Time •duration from the initial positive to subsequent negative peak •normal ↓ 500 μs
  • 33. EMGEMG Fibrillation Fasiculation Contraction of individual muscle fibre Contraction of individual motor units cannot be seen through the skin visible through the skin when muscle fibers lose contact with their innervating axon occurs as a result of additional nerve impulses generated 10-100 μV in amplitude, 1-2 ms in duration & 10 Hz in frequency 50-500 μV in amplitude, 2-4 ms in duration & 2-20 Hz in frequency Neuropathy, myopathy Neuropathy
  • 35. Muscle BiopsyMuscle Biopsy • If muscular dystrophy or myopathy is suspected.17 • Basic histology can identify myopathic, neuropathic, and dystrophic changes. • Immunohistochemical techniques using antibodies against muscle-specific proteins are helpful in the diagnosis of muscular dystrophies and myopathies. • Electron microscopy can identify abnormalities of organelles (such as mitochondria), and identify inclusions and storage material.
  • 36. Congenital Myotonic dystrophy • Mother previously diagnosed in 50% cases • Presents at birth • Hypotonia, facial diplegia with “tenting” of upper lip • Frequently severe respiratory distress secondary to intercostal and diaphragmatic muscle weakness Transient Neonatal Myasthenia • Mother usually previously diagnosed • Presents at birth or within few days • Muscle fatiguability, generalised weakness, hypotonia, weak cry, poor feeding, respiratory distress, ophthalmoplegia, ptosis (in 15%)
  • 37. Congenital Myotonic dystrophy • Poor suck, GI dysmotility • Reduced muscle mass, contractures • Maternal history: spont abortions, polyhydramnios, ↓ fetal movement, PPH, delayed 2nd stage • Triplet repeat Chr 19: AD Transient Neonatal Myasthenia • Normal pupils, normal DTR • Due to transplacental passage of maternal antibodies against acetyl choline receptor • Diagnosed by edrophonium test • Resolves in weeks
  • 38. SMASMA • A group of autosomal-recessive disorders characterized by progressive weakness of the lower motor neurons. • In the early 1980s, Werdnig and Hoffman described a disorder of progressive muscular weakness beginning in infancy that resulted in early death, though the age of death was variable.
  • 39. SMASMA • Incidence 1 in 10,000 live births with a carrier frequency of approximately 1 in 50. • Male individuals are most frequently affected, especially with the early-onset forms of spinal muscular atrophy, ie, types I and II. • SMA type I, the median survival is 7 months, with a mortality rate of 95% by age 18 months.
  • 40. SMA - TypesSMA - Types • Acute infantile (SMA type I, or Werdnig-Hoffman disease) onset birth to 6 months, Never sits • Chronic infantile (SMA type II), 6-18 months, Sits but can`t walk, • Chronic juvenile (SMA type III or Kugelberg- Welander disease), after 18 months, can walk. • Adult onset (SMA type IV) forms. Mid 30. • The genetic defects associated with SMA types I-III are localized on chromosome 5q
  • 41. SMA - PathophysiologySMA - Pathophysiology • Each individual has 2 SMN(Survivor Motor Neuron) genes, SMN1 and SMN2. • More than 95% of patients with spinal muscular atrophy have a homozygous disruption in the SMN1 gene on chromosome 5q, caused by mutation, deletion, or rearrangement. • However, all patients with spinal muscular atrophy retain at least 1 copy of SMN2, which generates only 10% of the amount of full-length SMN protein versus SMN1.
  • 42. SMA - Clinical FeaturesSMA - Clinical Features • 95% of patients symptomatic by 3 months. • They have severe, progressive muscle weakness and hypotonia. • Bulbar dysfunction includes poor suck ability, reduced swallowing, and respiratory failure. • Patients have no involvement of the extraocular muscles • Facial weakness is often minimal or absent. • No evidence of cerebral involvement, and infants appear alert.
  • 43. SMA - DiagnosisSMA - Diagnosis • The creatine kinase (CK) level is typically normal in SMA type I and normal or slightly elevated. • EMG shows fibrillation and muscle denervation.
  • 44. SMA - DiagnosisSMA - Diagnosis • Homozygous SMN1 gene deletion is 95% sensitive and nearly 100% specific for the diagnosis of SMA. • The accuracy of prenatal prediction by means of chorionic villi sampling and amniocentesis was 88-99%.
  • 45. SMA - DiagnosisSMA - Diagnosis